These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7138139)

  • 1. Species differences in the kinetics and metabolism of fenfluramine isomers.
    Caccia S; Ballabio M; Guiso G; Rocchetti M; Garattini S
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):15-28. PubMed ID: 7138139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of fenfluramine isomers in the rat.
    Caccia S; Dagnino G; Garattini S; Guiso G; Madonna R; Zanini MG
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):297-301. PubMed ID: 7333330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective disposition of fenfluramine enantiomers in the rat.
    Jori A; De Ponte P; Caccia S
    Xenobiotica; 1978 Sep; 8(9):583-8. PubMed ID: 695701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in mouse, rat, dog and man.
    Marchant NC; Breen MA; Wallace D; Bass S; Taylor AR; Ings RM; Campbell DB; Williams J
    Xenobiotica; 1992 Nov; 22(11):1251-66. PubMed ID: 1492418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of (-)-fenfluramine and its active metabolite, (-)-norfenfluramine in rat: a single dose-proportionality study.
    Spinelli R; Fracasso C; Guiso G; Garattini S; Caccia S
    Xenobiotica; 1988 May; 18(5):573-84. PubMed ID: 3400275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain.
    Clausing P; Newport GD; Bowyer JF
    J Pharmacol Exp Ther; 1998 Feb; 284(2):618-24. PubMed ID: 9454806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
    Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
    Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
    Klotz U; Antonin KH; Bieck PR
    J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of D-fenfluramine in lean and obese rats.
    Fracasso C; Guiso G; Garattini S; Caccia S
    Appetite; 1988 Feb; 10(1):45-55. PubMed ID: 3355126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given D- and DL-fenfluramine for 15 days.
    Caccia S; Conforti I; Duchier J; Garattini S
    Eur J Clin Pharmacol; 1985; 29(2):221-4. PubMed ID: 4076322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of fenfluramine enantiomers in man.
    Caccia S; Ballabio M; De Ponte P
    Eur J Drug Metab Pharmacokinet; 1979; 4(3):129-32. PubMed ID: 527596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The measurement of d-fenfluramine and its metabolite, d-norfenfluramine in plasma and urine with an application of the method to pharmacokinetic studies.
    Richards RP; Gordon BH; Ings RM; Campbell DB; King LJ
    Xenobiotica; 1989 May; 19(5):547-53. PubMed ID: 2750211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in the metabolism of suprofen in laboratory animals and man.
    Mori Y; Kuroda N; Sakai Y; Yokoya F; Toyoshi K; Baba S
    Drug Metab Dispos; 1985; 13(2):239-45. PubMed ID: 2859175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
    Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting species differences in the kinetics of metabolites of trichloroethylene.
    Templin MV; Stevens DK; Stenner RD; Bonate PL; Tuman D; Bull RJ
    J Toxicol Environ Health; 1995 Apr; 44(4):435-47. PubMed ID: 7723076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
    Cook CS; Karim A; Sollman P
    Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an O-glucuronide metabolite of the CCK-B antagonist LY288513 and its plasma levels in mouse, rat, and dog.
    Woodland JM; Ehlhardt WJ
    Drug Metab Dispos; 1995 Sep; 23(9):910-5. PubMed ID: 8565780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.